BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27086810)

  • 1. Postprandial Reactive Hypoglycemia Treated with a Low-dose Alpha-glucosidase Inhibitor: Voglibose May Suppress Oxidative Stress and Prevent Endothelial Dysfunction.
    Suzuki K; Katsura D; Sagara M; Aoki C; Nishida M; Aso Y
    Intern Med; 2016; 55(8):949-53. PubMed ID: 27086810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal reactive hypoglycaemia well treated subjectively and objectively with voglibose.
    Koyama H; Ohguchi H; Yagi T; Imaeda K
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients.
    Satoh N; Shimatsu A; Yamada K; Aizawa-Abe M; Suganami T; Kuzuya H; Ogawa Y
    Metabolism; 2006 Jun; 55(6):786-93. PubMed ID: 16713439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.
    Yamazaki K; Inoue T; Yasuda N; Sato Y; Nagakura T; Takenaka O; Clark R; Saeki T; Tanaka I
    J Pharmacol Sci; 2007 May; 104(1):29-38. PubMed ID: 17485917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
    Matsumura M; Monden T; Miyashita Y; Kawagoe Y; Shimizu H; Nakatani Y; Domeki N; Yanagi K; Ikeda S; Kasai K
    Adv Ther; 2009 Jun; 26(6):660-6. PubMed ID: 19568704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.
    Fujita Y; Tamada D; Kozawa J; Kobayashi Y; Sasaki S; Kitamura T; Yasuda T; Maeda N; Otsuki M; Okita K; Iwahashi H; Kaneto H; Funahashi T; Imagawa A; Shimomura I
    Intern Med; 2012; 51(18):2581-5. PubMed ID: 22989830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy.
    Taira M; Takasu N; Komiya I; Taira T; Tanaka H
    Metabolism; 2000 Apr; 49(4):440-3. PubMed ID: 10778865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Food Thickeners on the Inhibitory Effect of Voglibose Oral-disintegrating Tablets on Post-prandial Elevation of Blood Sugar Levels.
    Tomita T; Goto H; Sumiya K; Yoshida T; Tanaka K; Kohda Y
    Yakugaku Zasshi; 2016; 136(8):1171-6. PubMed ID: 27477734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Nakamura J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
    Moritoh Y; Takeuchi K; Hazama M
    J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
    Hariya N; Mochizuki K; Inoue S; Saito M; Fuchigami M; Goda T; Osonoi T
    Drugs R D; 2014 Sep; 14(3):177-84. PubMed ID: 25079671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
    Hedrington MS; Davis SN
    Expert Opin Pharmacother; 2019 Dec; 20(18):2229-2235. PubMed ID: 31593486
    [No Abstract]   [Full Text] [Related]  

  • 13. Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
    Asakura M; Kim J; Asanuma H; Hamasaki T; Tsukahara K; Higashino Y; Ishikawa T; Nakama Y; Koba S; Maruyama Y; Tsujimoto M; Himeno H; Ohkusa T; Fujino S; Shimizu M; Endo T; Yoda S; Muroya T; Murohara T; Ohte N; Suzuki H; Kohno T; Fukui K; Shiono T; Takase H; Uzui H; Nagai Y; Hashimoto Y; Ikeda S; Mizuno S; Tamita K; Fujita M; Satake K; Kinoshita Y; Nunohiro T; Sakagami S; Higaki J; Morii I; Sawada R; Hiasa Y; Shigemasa T; Nakahama M; Sata M; Doi O; Ueda T; Yamada T; Yamanouchi T; Yamaguchi H; Morita Y; Hayashi H; Kitakaze M;
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):401-411. PubMed ID: 28779371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms.
    Fujisawa T; Ikegami H; Inoue K; Kawabata Y; Ogihara T
    Metabolism; 2005 Mar; 54(3):387-90. PubMed ID: 15736118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.
    Kawamori R; Tajima N; Iwamoto Y; Kashiwagi A; Shimamoto K; Kaku K;
    Lancet; 2009 May; 373(9675):1607-14. PubMed ID: 19395079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial reactive hypoglycemia in an oldest-old patient effectively treated with low-dose acarbose.
    Tamura Y; Araki A; Chiba Y; Horiuchi T; Mori S; Hosoi T
    Endocr J; 2006 Dec; 53(6):767-71. PubMed ID: 16966825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
    Fujitani Y; Fujimoto S; Takahashi K; Satoh H; Hirose T; Hiyoshi T; Ai M; Okada Y; Gosho M; Mita T; Watada H
    Diabetes Res Clin Pract; 2016 Nov; 121():146-156. PubMed ID: 27710821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hypoglycaemia in a patient with type Ib glycogen storage disease by an amylase (alpha-glucosidase) inhibitor.
    Ihara K; Kuromaru R; Ryu A; Fukushige J; Hara T
    Acta Paediatr; 1998 May; 87(5):595-8. PubMed ID: 9641747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.
    Liao Y; Takashima S; Zhao H; Asano Y; Shintani Y; Minamino T; Kim J; Fujita M; Hori M; Kitakaze M
    Cardiovasc Res; 2006 Apr; 70(1):107-16. PubMed ID: 16510136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.
    Hirose S; Iwahashi Y; Seo A; Sumiyoshi M; Takahashi T; Tamori Y
    Intern Med; 2016; 55(9):1137-42. PubMed ID: 27150868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.